首页 > 最新文献

Journal of Patient-Reported Outcomes最新文献

英文 中文
Development of a conceptual model of BKV impacts on health-related quality of life in kidney transplant recipients: a qualitative study. BKV对肾移植受者健康相关生活质量影响的概念模型的建立:一项定性研究
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-07 DOI: 10.1186/s41687-025-00987-x
Courtney N Hurt, Maja Kuharic, Sara Shaunfield, Juergen Beck, Alex Bastian, Kevin Fowler, Emilie Jaeger, Marcus May, Erik van den Berg, John Friedewald, John D Peipert
{"title":"Development of a conceptual model of BKV impacts on health-related quality of life in kidney transplant recipients: a qualitative study.","authors":"Courtney N Hurt, Maja Kuharic, Sara Shaunfield, Juergen Beck, Alex Bastian, Kevin Fowler, Emilie Jaeger, Marcus May, Erik van den Berg, John Friedewald, John D Peipert","doi":"10.1186/s41687-025-00987-x","DOIUrl":"10.1186/s41687-025-00987-x","url":null,"abstract":"","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"4"},"PeriodicalIF":2.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12789305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploration of the relevance and comprehensibility of the European Organization for the Research and Treatment of Cancer Sexual Health Questionnaire among Danish young adults aged 18-39: a national cross-sectional study. 探索欧洲癌症研究和治疗组织性健康问卷在18-39岁丹麦青年中的相关性和可理解性:一项全国性横断面研究。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-31 DOI: 10.1186/s41687-025-00988-w
Maria Aagesen, Helle Pappot, Karin Piil, Ligita Paskeviciute Frøding, Emma Balch Steen-Olsen, Elfriede Greimel, Line Bentsen
{"title":"Exploration of the relevance and comprehensibility of the European Organization for the Research and Treatment of Cancer Sexual Health Questionnaire among Danish young adults aged 18-39: a national cross-sectional study.","authors":"Maria Aagesen, Helle Pappot, Karin Piil, Ligita Paskeviciute Frøding, Emma Balch Steen-Olsen, Elfriede Greimel, Line Bentsen","doi":"10.1186/s41687-025-00988-w","DOIUrl":"10.1186/s41687-025-00988-w","url":null,"abstract":"","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"3"},"PeriodicalIF":2.9,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145865799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confirming content validity of The Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) among adults with insomnia in four European countries. 在四个欧洲国家的成人失眠症患者中确认失眠日间症状和影响问卷(IDSIQ)的内容效度。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-29 DOI: 10.1186/s41687-025-00972-4
Andrea Phillips-Beyer, Ariane K Kawata, Leah Kleinman, Antonio Olivieri
{"title":"Confirming content validity of The Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) among adults with insomnia in four European countries.","authors":"Andrea Phillips-Beyer, Ariane K Kawata, Leah Kleinman, Antonio Olivieri","doi":"10.1186/s41687-025-00972-4","DOIUrl":"10.1186/s41687-025-00972-4","url":null,"abstract":"","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":"9 1","pages":"143"},"PeriodicalIF":2.9,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145858105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient- and clinician-reported acute radiation-induced diarrhoea in patients with prostate cancer during curative external radiation therapy: A prospective observational cohort study. 一项前瞻性观察队列研究:患者和临床报告的前列腺癌患者在治疗性外放射治疗期间急性放射诱发腹泻。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-24 DOI: 10.1186/s41687-025-00957-3
Mette Overgaard Holm, Ursula Falkmer, Randi Tobberup, Martin Skovmos Nielsen, Bjarke Mortensen, Rasmus Froberg Brøndum, Christine Vestergård Madsen, Henrik Højgaard Rasmussen, Mette Karen Yilmaz, Jimmi Søndergaard, Mette Moe, Laurids Østergaard Poulsen
{"title":"Patient- and clinician-reported acute radiation-induced diarrhoea in patients with prostate cancer during curative external radiation therapy: A prospective observational cohort study.","authors":"Mette Overgaard Holm, Ursula Falkmer, Randi Tobberup, Martin Skovmos Nielsen, Bjarke Mortensen, Rasmus Froberg Brøndum, Christine Vestergård Madsen, Henrik Højgaard Rasmussen, Mette Karen Yilmaz, Jimmi Søndergaard, Mette Moe, Laurids Østergaard Poulsen","doi":"10.1186/s41687-025-00957-3","DOIUrl":"10.1186/s41687-025-00957-3","url":null,"abstract":"","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"15"},"PeriodicalIF":2.9,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145820942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stakeholder input on the CAHPS ambulatory surveys. 持份者对CAHPS流动调查的意见。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-22 DOI: 10.1186/s41687-025-00983-1
Ron D Hays, Julie A Brown, Emma Bianculli, Marc Elliott
<p><strong>Background: </strong>The Consumer Assessment of Healthcare Providers and Systems (CAHPS<sup>®</sup>) surveys are widely used to evaluate patients' experiences with healthcare. Although the surveys have been extensively assessed and periodically updated, concerns persist regarding their content, length, and score distributions. This study aimed to gather systematic stakeholder feedback to inform future revisions of CAHPS ambulatory surveys.</p><p><strong>Methodology: </strong>A modified Delphi method was employed using the ExpertLens™ online platform. A panel of 20 members representing a broad stakeholder community, including survey sponsors, survey experts, patient experience advocates, and federal representatives, participated in three phases. The first phase was an initial rating of the essentialness (required, optional, not essential) of 46 existing item topics using a 1 (Not Essential) to 9 (Very Essential) scale with scores of 1-3 used for a topic that should not be included, 4-6 used for a topic that should be optional, and 7-9 for a topic that should be required in a CAHPS survey of health plans, clinicians, or group practices. The second phase was an asynchronous online discussion of the initial ratings, and the third phase was a final rating of the 46 existing item topics. The reliability of ratings was assessed using a mixed-effects analysis of variance model. Means and standard deviations of essentialness ratings were also analyzed. Verbatim comments from the experts were summarized to provide additional insights.</p><p><strong>Results: </strong>Reliability of expert 1-9 essentialness ratings improved from the initial round (reliability = 0.63, intraclass correlation = 0.08) to the final round (reliability = 0.70, intraclass correlation = 0.10). While most existing items were deemed essential by most stakeholders, there were noteworthy (0.08 or larger) increases from the initial to final rating phases in essentialness for items related to digital access, medication reconciliation, provider communication, and appeals processes, and notable decreases for specialist care ratings, access to medical questions during off-hours, and provider knowledge of chronic conditions. Stakeholders emphasized the importance of access to care, communication and coordination, respectful interactions with staff and providers, and clear cost information. Several potential topics missing from current surveys were identified, including unfair treatment, mental health integration, maternity care, language concordance, trust, self-management, patient safety, continuity of care, care coordination, and claims processing.</p><p><strong>Conclusions: </strong>This study provides valuable insights into stakeholder perspectives on the relevance and potential improvements to CAHPS ambulatory survey content. The findings support revisions to existing items to enhance their clarity and actionability, as well as the inclusion of new topics that reflect evolving
背景:消费者对医疗保健提供者和系统的评估(CAHPS®)调查被广泛用于评估患者的医疗保健体验。尽管调查已被广泛评估并定期更新,但对其内容、长度和分数分布的担忧仍然存在。本研究旨在收集系统的利益相关者反馈,为CAHPS动态调查的未来修订提供信息。方法学:采用改进的德尔菲法,采用ExpertLens™在线平台。一个由20名成员组成的小组,代表广泛的利益相关者社区,包括调查发起人、调查专家、患者体验倡导者和联邦代表,参与了三个阶段。第一阶段是对现有46个项目主题的重要性(必需的、可选的、非必需的)进行初步评级,使用1(非必需的)到9(非常必要的)量表,其中1-3分用于不应该包括的主题,4-6分用于应该是可选的主题,7-9分用于健康计划、临床医生或小组实践CAHPS调查中应该要求的主题。第二阶段是对初始评级进行异步在线讨论,第三阶段是对46个现有项目主题进行最终评级。使用混合效应方差分析模型评估评分的可靠性。还分析了重要性评分的均值和标准差。对专家的逐字评论进行了总结,以提供更多的见解。结果:专家1-9要素评分的信度从第一轮(信度= 0.63,类内相关= 0.08)到最后一轮(信度= 0.70,类内相关= 0.10)得到改善。虽然大多数现有项目被大多数利益相关者认为是必不可少的,但与数字访问、药物和解、提供者沟通和申诉程序相关的项目的重要性从最初到最终评级阶段有显著(0.08或更大)的增加,而专家护理评级、非工作时间获得医疗问题和提供者对慢性病的了解明显下降。利益攸关方强调了获得护理、沟通和协调、与工作人员和提供者相互尊重的互动以及明确成本信息的重要性。确定了当前调查中遗漏的几个潜在主题,包括不公平待遇、心理健康整合、产科护理、语言一致性、信任、自我管理、患者安全、护理连续性、护理协调和索赔处理。结论:本研究为利益相关者对CAHPS流动调查内容的相关性和潜在改进提供了有价值的见解。调查结果支持对现有项目进行修订,以提高其清晰度和可操作性,并纳入反映不断变化的医疗保健优先事项和患者需求的新主题。确定的扩展领域为在门诊护理环境中创建更全面和有影响力的患者体验评估提供了机会。
{"title":"Stakeholder input on the CAHPS ambulatory surveys.","authors":"Ron D Hays, Julie A Brown, Emma Bianculli, Marc Elliott","doi":"10.1186/s41687-025-00983-1","DOIUrl":"10.1186/s41687-025-00983-1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The Consumer Assessment of Healthcare Providers and Systems (CAHPS&lt;sup&gt;®&lt;/sup&gt;) surveys are widely used to evaluate patients' experiences with healthcare. Although the surveys have been extensively assessed and periodically updated, concerns persist regarding their content, length, and score distributions. This study aimed to gather systematic stakeholder feedback to inform future revisions of CAHPS ambulatory surveys.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methodology: &lt;/strong&gt;A modified Delphi method was employed using the ExpertLens™ online platform. A panel of 20 members representing a broad stakeholder community, including survey sponsors, survey experts, patient experience advocates, and federal representatives, participated in three phases. The first phase was an initial rating of the essentialness (required, optional, not essential) of 46 existing item topics using a 1 (Not Essential) to 9 (Very Essential) scale with scores of 1-3 used for a topic that should not be included, 4-6 used for a topic that should be optional, and 7-9 for a topic that should be required in a CAHPS survey of health plans, clinicians, or group practices. The second phase was an asynchronous online discussion of the initial ratings, and the third phase was a final rating of the 46 existing item topics. The reliability of ratings was assessed using a mixed-effects analysis of variance model. Means and standard deviations of essentialness ratings were also analyzed. Verbatim comments from the experts were summarized to provide additional insights.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Reliability of expert 1-9 essentialness ratings improved from the initial round (reliability = 0.63, intraclass correlation = 0.08) to the final round (reliability = 0.70, intraclass correlation = 0.10). While most existing items were deemed essential by most stakeholders, there were noteworthy (0.08 or larger) increases from the initial to final rating phases in essentialness for items related to digital access, medication reconciliation, provider communication, and appeals processes, and notable decreases for specialist care ratings, access to medical questions during off-hours, and provider knowledge of chronic conditions. Stakeholders emphasized the importance of access to care, communication and coordination, respectful interactions with staff and providers, and clear cost information. Several potential topics missing from current surveys were identified, including unfair treatment, mental health integration, maternity care, language concordance, trust, self-management, patient safety, continuity of care, care coordination, and claims processing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This study provides valuable insights into stakeholder perspectives on the relevance and potential improvements to CAHPS ambulatory survey content. The findings support revisions to existing items to enhance their clarity and actionability, as well as the inclusion of new topics that reflect evolving ","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"14"},"PeriodicalIF":2.9,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834880/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of a single question for assessment of habitual physical activity in women. 对女性习惯性体力活动评估的单一问题的验证。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-21 DOI: 10.1186/s41687-025-00986-y
Melissa J Benton, Andrea M Hutchins

Background: Accurate assessment of physical activity behaviors allows clinicians to target counseling more effectively. Single questions regarding habitual physical activity provide the most feasible option for rapid physical activity assessment. This study evaluated construct validity of a single item physical activity question to self-report habitual activity as simple categorical descriptors (not active, somewhat active, active, very active).

Methods: Women (N = 120) completed one laboratory session for measurement of self-reported physical activity (International Physical Activity Questionnaire-IPAQ), anthropometrics and body composition, and physical activity-related quality of life (SF-36 physical function subscale, Vitality Plus Scale). Construct validity was evaluated as convergent and known-groups validity.

Results: Mean age was 60 ± 16 years (range 25-89). The majority (62%) reported being active or very active. Age was not significantly related to activity levels. Correlation analysis demonstrated good convergent validity. Significant negative correlations were found with body weight, body mass index (BMI), waist circumference, and body fat (all p <0.001). Significant positive correlations were found with vigorous intensity activity (p <0.001), moderate intensity activity (p = .004), walking (p = .005), and quality of life (p <0.001). Good known-groups validity was demonstrated by significant differences between habitual physical activity levels for body weight, waist circumference, body fat, vigorous intensity activity (all p <0.001), moderate intensity activity (p = .038), walking (p = .049), and quality of life (p <0.001). Regression models confirmed known-groups validity.

Conclusions: A single question with categorical descriptors is valid for brief clinical assessment of habitual physical activity in women across a wide age range.

背景:对身体活动行为的准确评估使临床医生能够更有效地进行有针对性的咨询。关于习惯性体育活动的单一问题为快速体育活动评估提供了最可行的选择。本研究以单项体育活动问题作为简单的分类描述(不活动、有些活动、活动、非常活动)来评估自我报告习惯性活动的构式效度。方法:女性(N = 120)完成了一个实验室测试,测量自我报告的体力活动(国际体力活动问卷- ipaq)、人体测量和身体成分,以及体力活动相关的生活质量(SF-36身体功能量表,活力加量表)。构念效度评估为收敛效度和已知组效度。结果:平均年龄60±16岁(25 ~ 89岁)。大多数人(62%)表示自己很活跃或非常活跃。年龄与活动量没有显著关系。相关分析显示有较好的收敛效度。体重、身体质量指数(BMI)、腰围和体脂之间存在显著的负相关(均为p)。结论:一个带有分类描述符的单一问题对于广泛年龄范围内女性习惯性身体活动的简短临床评估是有效的。
{"title":"Validation of a single question for assessment of habitual physical activity in women.","authors":"Melissa J Benton, Andrea M Hutchins","doi":"10.1186/s41687-025-00986-y","DOIUrl":"10.1186/s41687-025-00986-y","url":null,"abstract":"<p><strong>Background: </strong>Accurate assessment of physical activity behaviors allows clinicians to target counseling more effectively. Single questions regarding habitual physical activity provide the most feasible option for rapid physical activity assessment. This study evaluated construct validity of a single item physical activity question to self-report habitual activity as simple categorical descriptors (not active, somewhat active, active, very active).</p><p><strong>Methods: </strong>Women (N = 120) completed one laboratory session for measurement of self-reported physical activity (International Physical Activity Questionnaire-IPAQ), anthropometrics and body composition, and physical activity-related quality of life (SF-36 physical function subscale, Vitality Plus Scale). Construct validity was evaluated as convergent and known-groups validity.</p><p><strong>Results: </strong>Mean age was 60 ± 16 years (range 25-89). The majority (62%) reported being active or very active. Age was not significantly related to activity levels. Correlation analysis demonstrated good convergent validity. Significant negative correlations were found with body weight, body mass index (BMI), waist circumference, and body fat (all p <0.001). Significant positive correlations were found with vigorous intensity activity (p <0.001), moderate intensity activity (p = .004), walking (p = .005), and quality of life (p <0.001). Good known-groups validity was demonstrated by significant differences between habitual physical activity levels for body weight, waist circumference, body fat, vigorous intensity activity (all p <0.001), moderate intensity activity (p = .038), walking (p = .049), and quality of life (p <0.001). Regression models confirmed known-groups validity.</p><p><strong>Conclusions: </strong>A single question with categorical descriptors is valid for brief clinical assessment of habitual physical activity in women across a wide age range.</p>","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"13"},"PeriodicalIF":2.9,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative assessment of visual designs for communicating patient-reported outcomes in breast cancer care to patients. 视觉设计的定量评估,用于向患者传达患者报告的乳腺癌治疗结果。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-20 DOI: 10.1186/s41687-025-00984-0
Lea Doppelbauer, Anna Maria Hage, Maria Margarete Karsten, Pimrapat Gebert, Anna Tatzber, Laura Hatzler, Jasper Brands, Rosanne Andriessen, Therese Pross
{"title":"Quantitative assessment of visual designs for communicating patient-reported outcomes in breast cancer care to patients.","authors":"Lea Doppelbauer, Anna Maria Hage, Maria Margarete Karsten, Pimrapat Gebert, Anna Tatzber, Laura Hatzler, Jasper Brands, Rosanne Andriessen, Therese Pross","doi":"10.1186/s41687-025-00984-0","DOIUrl":"10.1186/s41687-025-00984-0","url":null,"abstract":"","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"12"},"PeriodicalIF":2.9,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12830510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a patient-reported-experience measure to ascertain treatment satisfaction in migraine: the MISAT-Q questionnaire. 开发和验证患者报告经验的措施,以确定治疗满意度在偏头痛:MISAT-Q问卷。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-15 DOI: 10.1186/s41687-025-00979-x
Ana B Gago-Veiga, Nuria González-García, Javier Díaz-de-Terán, Patricia Heredia-Rodríguez, Beatriz Armada-Peláez, Carlota Moya-Alarcón, Javier Soto-Álvarez, Javier Rejas-Gutiérrez, Miguel Á Ruiz-Díaz
<p><strong>Background: </strong>The patient's perspective is increasingly relevant in health decision making. In daily practice, care of patients with migraine should include evaluation of their satisfaction with acute and preventive treatments, the interference with daily living, as well as with the care received by the healthcare team. The aim was to develop and validate a novel specific self-reported patient-reported-experience measure (PREM) in Spanish (Spain), to ascertain satisfaction with migraine treatment; the MISAT-Q questionnaire.</p><p><strong>Methodology: </strong>A multicenter, crosssectional, non-interventional study was conducted between June 2023 and March 2024 in headache units in Spain. Patients with migraine currently receiving treatment were included. A 35-items preliminary instrument was developed after literature review and cognitive debriefing with experts and patients. Three samples were used: a) 23 patients to assess feasibility/pertinence of items; b) 158 patients for item reduction; and c) 209 patients for validation of PREM. Measures for concept validity included Patient Global Impression of change (PGI), Headache Impact Scale-6 items (HIT-6), and Health-Related Quality-of-life (EQ-5D-3 L). Feasibility, reliability and validity (content, discriminant, construct, and concurrent) were assessed.</p><p><strong>Results: </strong>Feasibility: face value (good acceptance to answer the questionnaire), administration time (below 10 minutes), floor and ceiling effects (below 40% in any extreme response category), percentage of missing values in each item (below 20%) was found in the validation sample. Factor analysis item reduction resulted in a 22-item questionnaire with 7 dimensions: undesirable side effects, treatment effectiveness in crisis and in prevention, convenience-of-use, impact on daily activities, medical care, and global satisfaction, supported with confirmatory factor analysis: CFI = 0.983; TLI = 0.980; χ<sup>2</sup>/df = 1.808; RMSEA = 0.075. Reliability was high: Cronbach's alpha = 0.90 and intraclass-correlation coefficient = 0.95. Dimensions of questionnaire showed significant and moderate convergent correlations with the overall score (0.58-0.68, p < 0.001). Concurrent validity with HIT-6 showed correlation's coefficients ranging from -0.19 to -0.48 (p < 0.01 in all cases, except medical care) and with EQ-5D-3 L (correlations from 0.17 to 0.39, p < 0.05 in all cases, except medical care). Differences in satisfaction were found according with migraine severity (F = 6.73, p = 0.002), as well as in HIT-6 scores (F = 8.20, p < 0.002). MISAT-Q discriminated overall satisfaction between patients with worse, no change and better change with treatment (F = 15.85; p < 0.001).</p><p><strong>Conclusions: </strong>The MISAT-Q questionnaire is a well-accepted, reliable and valid measure of migraine treatment satisfaction in Spanish. Responsiveness attribute needs to be explored. This novel PREM may facilitate clinicians
背景:患者的观点在健康决策中越来越重要。在日常实践中,偏头痛患者的护理应包括评估他们对急性和预防性治疗的满意度、对日常生活的干扰以及对医疗团队所接受的护理的满意度。目的是开发和验证一种新的特定的西班牙语自我报告患者报告经验测量(PREM),以确定偏头痛治疗的满意度;MISAT-Q问卷。方法:在2023年6月至2024年3月期间,在西班牙的头痛单位进行了一项多中心、横断面、非介入性研究。目前正在接受治疗的偏头痛患者也包括在内。通过文献回顾和专家、患者的认知情况汇报,初步编制了一套35项的量表。采用三个样本:a) 23例患者评估项目的可行性/针对性;B)减少项目158例;c) 209例患者验证PREM。概念效度的测量包括患者总体变化印象(PGI)、头痛影响量表-6 (HIT-6)和健康相关生活质量(eq - 5d - 3l)。评估可行性、信度和效度(内容、判别、建构和并发)。结果:可行性:在验证样本中发现了面值(回答问卷的良好接受度),给药时间(低于10分钟),地板和天花板效应(在任何极端反应类别中低于40%),每个项目的缺失值百分比(低于20%)。因子分析项目减少后,问卷共22项,共7个维度:不良反应、危机和预防治疗效果、使用便利性、对日常活动的影响、医疗保健、整体满意度,并支持验证性因子分析:CFI = 0.983;tli = 0.980;χ2/df = 1.808;rmsea = 0.075。信度高:Cronbach's alpha = 0.90,类内相关系数= 0.95。问卷维度与总分呈显著和中度收敛相关(0.58-0.68,p)。结论:MISAT-Q问卷是西班牙语患者偏头痛治疗满意度的一种被广泛接受、可靠和有效的测量方法。需要探索响应性属性。这种新颖的PREM可以帮助临床医生在偏头痛患者的治疗管理中做出健康决策。
{"title":"Development and validation of a patient-reported-experience measure to ascertain treatment satisfaction in migraine: the MISAT-Q questionnaire.","authors":"Ana B Gago-Veiga, Nuria González-García, Javier Díaz-de-Terán, Patricia Heredia-Rodríguez, Beatriz Armada-Peláez, Carlota Moya-Alarcón, Javier Soto-Álvarez, Javier Rejas-Gutiérrez, Miguel Á Ruiz-Díaz","doi":"10.1186/s41687-025-00979-x","DOIUrl":"10.1186/s41687-025-00979-x","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The patient's perspective is increasingly relevant in health decision making. In daily practice, care of patients with migraine should include evaluation of their satisfaction with acute and preventive treatments, the interference with daily living, as well as with the care received by the healthcare team. The aim was to develop and validate a novel specific self-reported patient-reported-experience measure (PREM) in Spanish (Spain), to ascertain satisfaction with migraine treatment; the MISAT-Q questionnaire.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methodology: &lt;/strong&gt;A multicenter, crosssectional, non-interventional study was conducted between June 2023 and March 2024 in headache units in Spain. Patients with migraine currently receiving treatment were included. A 35-items preliminary instrument was developed after literature review and cognitive debriefing with experts and patients. Three samples were used: a) 23 patients to assess feasibility/pertinence of items; b) 158 patients for item reduction; and c) 209 patients for validation of PREM. Measures for concept validity included Patient Global Impression of change (PGI), Headache Impact Scale-6 items (HIT-6), and Health-Related Quality-of-life (EQ-5D-3 L). Feasibility, reliability and validity (content, discriminant, construct, and concurrent) were assessed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Feasibility: face value (good acceptance to answer the questionnaire), administration time (below 10 minutes), floor and ceiling effects (below 40% in any extreme response category), percentage of missing values in each item (below 20%) was found in the validation sample. Factor analysis item reduction resulted in a 22-item questionnaire with 7 dimensions: undesirable side effects, treatment effectiveness in crisis and in prevention, convenience-of-use, impact on daily activities, medical care, and global satisfaction, supported with confirmatory factor analysis: CFI = 0.983; TLI = 0.980; χ&lt;sup&gt;2&lt;/sup&gt;/df = 1.808; RMSEA = 0.075. Reliability was high: Cronbach's alpha = 0.90 and intraclass-correlation coefficient = 0.95. Dimensions of questionnaire showed significant and moderate convergent correlations with the overall score (0.58-0.68, p &lt; 0.001). Concurrent validity with HIT-6 showed correlation's coefficients ranging from -0.19 to -0.48 (p &lt; 0.01 in all cases, except medical care) and with EQ-5D-3 L (correlations from 0.17 to 0.39, p &lt; 0.05 in all cases, except medical care). Differences in satisfaction were found according with migraine severity (F = 6.73, p = 0.002), as well as in HIT-6 scores (F = 8.20, p &lt; 0.002). MISAT-Q discriminated overall satisfaction between patients with worse, no change and better change with treatment (F = 15.85; p &lt; 0.001).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The MISAT-Q questionnaire is a well-accepted, reliable and valid measure of migraine treatment satisfaction in Spanish. Responsiveness attribute needs to be explored. This novel PREM may facilitate clinicians ","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"10"},"PeriodicalIF":2.9,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12819897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145757901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing observer-reported outcome measurement: development of the MOOD-AS for observing distress in Angelman syndrome. 推进观察者报告的结果测量:MOOD-AS在Angelman综合征中观察苦恼的发展。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-12 DOI: 10.1186/s41687-025-00975-1
Sean N Halpin, Doesjka A Hagenaar, Sarah Nelson Potter, Emma van Wooning, Angela Gwaltney, Sabine E Mous, Anne C Wheeler
{"title":"Advancing observer-reported outcome measurement: development of the MOOD-AS for observing distress in Angelman syndrome.","authors":"Sean N Halpin, Doesjka A Hagenaar, Sarah Nelson Potter, Emma van Wooning, Angela Gwaltney, Sabine E Mous, Anne C Wheeler","doi":"10.1186/s41687-025-00975-1","DOIUrl":"10.1186/s41687-025-00975-1","url":null,"abstract":"","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":" ","pages":"8"},"PeriodicalIF":2.9,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12816459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145744876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes. 患者报告了人工晶状体问卷(PR-ILQ):内容效度、心理测量表现和在规范临床试验中的使用,以评估安全性和有效性结果。
IF 2.9 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-12 DOI: 10.1186/s41687-025-00968-0
Alan L Shields, Nina Galipeau, Leighann Litcher-Kelly, Alejandro Moreno-Koehler, Jimmy Chacko
<p><strong>Background: </strong>Patient-reported outcomes (PROs) are underutilized in medical device evaluations, including in ophthalmology and intraocular lens (IOL) replacements. This article summarizes research conducted to develop the Patient-Reported Intraocular Lens Questionnaire (PR-ILQ) and support its content validity and psychometric performance. Use of the PR-ILQ in a regulated clinical trial to support new product approval decisions, secondary effectiveness claims, and safety observations is also discussed.</p><p><strong>Results: </strong>The PR-ILQ, developed with ophthalmology experts (n = 10) and use of qualitative data generated from patients during concept elicitation (n = 44) and cognitive debriefing (n = 32) interviews, includes the Vision Correction Scale (VCS, three items), Vision Disturbance Scale (VDS, eight items), and IOL Replacement Satisfaction Scale (IOL-RSS, five items). Each assessment is distinct, and items within each are scored independently to address treatment benefit hypotheses. With its content validity established, the PR-ILQ was administered to 271 subjects (mean age = 68.3 years) participating in a clinical trial to evaluate the safety and effectiveness of an asymmetric segmented multifocal IOL (SBL-INI-02-13). Descriptively, item scores behaved as expected, with clustering of VCS and VDS scores at more- and less-severe levels at study entry and exit, respectively, though scores were distributed across response options across timepoints. Test-retest reliability results mostly indicate "fair"/"good" (weighted Kappa [KW]/intraclass correlation coefficient [ICC] > 0.40 to 0.60) to "excellent" (KW/ICC > 0.75) reproducibility for VCS, VDS, and IOL-RSS items in two independent analyses. Construct validity hypotheses, including those associated with sensitivity to change, were supported via correlational analysis showing a pattern of expected relationships among PR-ILQ items and with other variables including ratings of visual acuity. For example, reduced use of vision correction at near (r = -0.28), intermediate (r = -0.42), and far (r = -0.57) distances were more strongly related to overall lens satisfaction at end of study than improved visual acuity at those same distances (r = -0.25. -0.26, and -0,14).</p><p><strong>Conclusions: </strong>The PR-ILQ is content valid and early evidence suggests it is capable of producing reliable scores upon which valid conclusions may be drawn when administered among patients undergoing cataract lens replacement surgery. Acknowledging limitations and need for additional psychometric evaluation, the assessment recently supported a new product approval decision, secondary effectiveness claims, and safety observations. Together, this indicates that the PR-ILQ, along with the evidentiary basis and suggestions for use presented herein, will be of immediate value to IOL replacement outcomes researchers, regulators, and other stakeholders interested in generating evidence to inform
背景:患者报告的结果(PROs)在医疗器械评估中未得到充分利用,包括眼科和人工晶状体(IOL)置换。本文综述了《患者报告型人工晶状体问卷》(PR-ILQ)的研究进展,并对其内容效度和心理测量性能进行了支持。在规范的临床试验中使用PR-ILQ来支持新产品批准决策、二次有效性声明和安全性观察也进行了讨论。结果:PR-ILQ是由眼科专家(n = 10)和使用患者在概念启发(n = 44)和认知汇报(n = 32)访谈过程中产生的定性数据制定的,包括视力矫正量表(VCS, 3个项目)、视力障碍量表(VDS, 8个项目)和人工晶状体置换满意度量表(IOL- rss, 5个项目)。每个评估都是不同的,每个评估中的项目都是独立评分的,以解决治疗益处假设。PR-ILQ的内容效度建立后,对271名平均年龄为68.3岁的受试者进行了临床试验,以评估非对称节段多焦人工晶体的安全性和有效性(SBL-INI-02-13)。描述性地,项目得分表现如预期,VCS和VDS得分在研究进入和退出时分别聚集在更严重和更不严重的水平上,尽管得分分布在不同时间点的不同反应选项上。在两个独立分析中,重测信度结果大多表明VCS、VDS和IOL-RSS项目的再现性为“一般”/“良好”(加权Kappa [KW]/类内相关系数[ICC] > 0.40 ~ 0.60)到“优秀”(KW/ICC > 0.75)。建构效度假设,包括那些与变化敏感性相关的假设,通过相关分析得到支持,显示了PR-ILQ项目之间的预期关系模式以及与其他变量(包括视觉敏度评级)的预期关系。例如,研究结束时,近距离(r = -0.28)、中距离(r = -0.42)和远距离(r = -0.57)视力矫正使用的减少与整体晶状体满意度的关系比相同距离(r = -0.25)视力改善的关系更强。-0.26,和-0,14)。结论:PR-ILQ是内容有效的,早期证据表明它能够产生可靠的评分,在此基础上可以得出有效的结论,当患者接受白内障晶状体置换术时。承认局限性和需要额外的心理测量评估,评估最近支持了新产品批准决定,次要有效性声明和安全性观察。总之,这表明PR-ILQ,以及本文提出的证据基础和使用建议,将对人工晶状体置换结果研究人员、监管机构和其他对产生证据以告知医疗保健决策和改善白内障患者生活感兴趣的利益相关者具有直接价值。试验注册:Clinicaltrials.gov, NCT02487160。2015年6月25日注册,https://clinicaltrials.gov/study/NCT02487160。
{"title":"The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes.","authors":"Alan L Shields, Nina Galipeau, Leighann Litcher-Kelly, Alejandro Moreno-Koehler, Jimmy Chacko","doi":"10.1186/s41687-025-00968-0","DOIUrl":"10.1186/s41687-025-00968-0","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Patient-reported outcomes (PROs) are underutilized in medical device evaluations, including in ophthalmology and intraocular lens (IOL) replacements. This article summarizes research conducted to develop the Patient-Reported Intraocular Lens Questionnaire (PR-ILQ) and support its content validity and psychometric performance. Use of the PR-ILQ in a regulated clinical trial to support new product approval decisions, secondary effectiveness claims, and safety observations is also discussed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The PR-ILQ, developed with ophthalmology experts (n = 10) and use of qualitative data generated from patients during concept elicitation (n = 44) and cognitive debriefing (n = 32) interviews, includes the Vision Correction Scale (VCS, three items), Vision Disturbance Scale (VDS, eight items), and IOL Replacement Satisfaction Scale (IOL-RSS, five items). Each assessment is distinct, and items within each are scored independently to address treatment benefit hypotheses. With its content validity established, the PR-ILQ was administered to 271 subjects (mean age = 68.3 years) participating in a clinical trial to evaluate the safety and effectiveness of an asymmetric segmented multifocal IOL (SBL-INI-02-13). Descriptively, item scores behaved as expected, with clustering of VCS and VDS scores at more- and less-severe levels at study entry and exit, respectively, though scores were distributed across response options across timepoints. Test-retest reliability results mostly indicate \"fair\"/\"good\" (weighted Kappa [KW]/intraclass correlation coefficient [ICC] &gt; 0.40 to 0.60) to \"excellent\" (KW/ICC &gt; 0.75) reproducibility for VCS, VDS, and IOL-RSS items in two independent analyses. Construct validity hypotheses, including those associated with sensitivity to change, were supported via correlational analysis showing a pattern of expected relationships among PR-ILQ items and with other variables including ratings of visual acuity. For example, reduced use of vision correction at near (r = -0.28), intermediate (r = -0.42), and far (r = -0.57) distances were more strongly related to overall lens satisfaction at end of study than improved visual acuity at those same distances (r = -0.25. -0.26, and -0,14).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The PR-ILQ is content valid and early evidence suggests it is capable of producing reliable scores upon which valid conclusions may be drawn when administered among patients undergoing cataract lens replacement surgery. Acknowledging limitations and need for additional psychometric evaluation, the assessment recently supported a new product approval decision, secondary effectiveness claims, and safety observations. Together, this indicates that the PR-ILQ, along with the evidentiary basis and suggestions for use presented herein, will be of immediate value to IOL replacement outcomes researchers, regulators, and other stakeholders interested in generating evidence to inform ","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":"9 1","pages":"142"},"PeriodicalIF":2.9,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12701150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145744793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Patient-Reported Outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1